Skip to main content

Frank Vinluan - MedCityNews

Articles From This Author

NYSE tumbleweed
Health

The Biopharma Investment Outlook for 2025

By Frank Vinluan - MedCityNews
fda
Health

FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions

By Frank Vinluan - MedCityNews
money in hands
Private Equity

Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition

By Frank Vinluan - MedCityNews
pills 3
Pharma

SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition

By Frank Vinluan - MedCityNews
eu court of justice
Mergers & Acquisitions

Illumina’s European Court Victory Can’t Salvage Grail Acquisition, But It Nullifies Hefty Fine

By Frank Vinluan - MedCityNews
pills 3
Venture Capital

Biotech Financing Roundup: Jade Bio’s Launch, Brenig’s Debut, Confo’s Cash & More

By Frank Vinluan - MedCityNews
AspyreRx
News

With M&A Deal, Click Therapeutics’ Digital Prospects in Metabolic Disease Get Better

By Frank Vinluan - MedCityNews
genetic testing
Mergers & Acquisitions

Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction

By Frank Vinluan - MedCityNews
nasdaq
News

ArriVent’s Nasdaq Debut Nabs $175M as Signs Indicate an Opening IPO Window

By Frank Vinluan - MedCityNews
paxlovid
News

Ex-Pfizer Employee Convicted for Insider Trades Ahead of Positive Paxlovid Data

By Frank Vinluan - MedCityNews
200west
Banks

Goldman Sachs Closes $650M Fund to Invest in ‘Golden Era’ of Biotech Innovation

By Frank Vinluan - MedCityNews
dna
News

EU Orders Grail Sale

By Frank Vinluan - MedCityNews
crispr
Venture Capital

Startup Syntax Bio Leverages CRISPR to Transform Cell Therapy Manufacturing

By Frank Vinluan - MedCityNews
vaccine shot
News

FDA Approves Updated Covid-19 Vaccines to Address Now Circulating Variants

By Frank Vinluan - MedCityNews
amgen
Market News

Amgen, FTC Settlement Allows $28B Horizon Acquisition to Move Forward

By Frank Vinluan - MedCityNews
pills 3
News

Still Hungry for New Obesity Meds, Novo Nordisk Makes Another M&A Deal

By Frank Vinluan - MedCityNews
vaccine shot
News

Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B

By Frank Vinluan - MedCityNews
amgen
News

FTC Files Suit to Block Amgen’s $28B Buyout of Horizon Therapeutics

By Frank Vinluan - MedCityNews
coronavirus
News

FDA Authorizes First Covid-19 and Flu Test, But Its Maker Files for Bankruptcy

By Frank Vinluan - MedCityNews
NYSE tumbleweed
News

Biotech IPO Freeze Continues As Second Quarter Is Slowest In More Than A Decade

By Frank Vinluan - MedCityNews
glasses eye chart
News

Bausch + Lomb Eyes IPO

By Frank Vinluan - MedCityNews